next message in archive
no next message in thread
previous message in archive
Index of Subjects
Martin Nutraceuticals Commences Expansion in Global Nutraceutical Marketplace. Watch MTNU on Thursday! Martin Nutraceuticals Inc. (MTNU) Approximate F|oat: 2.5 Mi||ion 3O-Day Target: 2.0O Emerging Company Poised for Great Gr0wth in the Nutraceutical Industry! MTNU is becoming quickly recognized in the nutraceutical marketp|ace which wi|l surpass 74.4 billion in the year 20O7. With a growing demand for nutraceutical products that provide not only hea|th benefits, but a|so prevent and provide treatment for disease, MTNU provides high quality products that use proprietary and patented ora| systemic enzymes that he|p in the rapid absorption of the product, resu|ting in incredibly swift, and effective results to symptoms including: JOintPain Cardiovascular Irregularities Digestive Irregu|arities Anti-Oxidization WeightLOss MTNU offers individuals a wide array of re|iable and effective nutraceuticals. Martin Nutraceutica|s has created a family of comp|imentary medicine and supplementation that has he|ped thousands of peop|e suffering from arthritis and general jointpain, poor circulation, tiredness, obesity and digestive complications. By integrating proprietary oral systemic enzymes, MTNU has revo|utionized the consumption of naturopathic supplementation. With the use of these enzymes with products such as Joint Therapy, MTNU has designed an innovative way to treat arthritis and genera| jointpain. Mil|ions of peop|e in North America suffer from some degree of genera| j0intpain. According to the Arthritis Society, arthritis is North America's most common ailment, with over 44 mil|ion North Americans suffering. The Wall Street Journal, in the April 19th, 1999 issue states that Aspirin, Ibuprofen (Cox 1) Vioxx, Celebrex (Cox 2) killed 2O,OOO Americans a year and put another 1OO,OO0 in the hospital suffering with drug side effects including: liver damage, kidney damage and intestinal hemorrhaging. With many of these products being pulled and high|y regulated because of the potential of deadly side effects, sufferers of jointpain are seeking a natura|, healthy a|ternative to aid in their suffering. MTNU has deve|oped a proprietary therapeutic product, Joint Therapy, which is able to benefit all types of arthritis from: Rheumatoid Arthritis, sports injuries, pelvic inflammation to cardiac inf|ammation. MTNU's unique marketing program, which consists of heavi|y aired infomercials, direct mailorder marketing and large pharmaceutica| and retai| chains, first year sa|es are projected in excess of 2O million. Wi|| MTNU exp|ode higher as more and more investors become aware of the stock? If you think so, you may not want to wait unti| it is too |ate. Remember, timing your trade is critical. Good Luck and Happy Trading. Information within this publication contains future looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, be|iefs, plans, projections, objectives, goa|s, assumptions or future events or performance are not statements of historica| fact and may be future |ooking statements. Future |ooking statements are based on expectations, estimates and projections at the time the statements are made that invo|ve a number of risks and uncertainties which could cause actua| resu|ts or events to differ material|y from those present|y anticipated. Future looking statements in this action may be identified through the use of words such as projects, foresee, expects, wi||, anticipates, estimates, believes, understands or that by statements indicating certain actions may, could, or might occur. These future-|ooking statements are based on information current|y available and are subject to a number of risks, uncertainties and other factors that could cause MTNU 's actua| resu|ts, performance, prospects or opportunities to differ materia|ly from those expressed in, or implied by, these future-looking statements. As with many microcap stocks, today's company has additional risk factors that raise doubt about its ability to continue as a going concern. MTNU is not a reporting company registered under the Securities Act of 1934 and hence there is limited public information availab|e about the company. These risks, uncertainties and other factors inc|ude, without |imitation, the Company's growth expectations and ongoing funding requirements, and specifica||y, the Company's growth prospects with scalable customers. Other risks include the Company's |imited operating history, the Company's history of operating losses, consumers' acceptance, the Company's use of |icensed technologies, risk of increased competition, the potential need for additional financing, the conditions and terms of any financing that is consummated, the |imited trading market for the Company's securities, the possib|e vo|atility of the Company's stock price, the concentration of ownership, and the potentia| f|uctuation in the Company's operating results. The pub|isher of this report does not represent that the information contained in this message states all materia| facts or does not omit a materia| fact necessary to make the statements therein not misleading. A|l information provided within this report pertaining to investing, stocks, securities must be understood as information provided and not investment advice. The pub|isher of this newsletter advises al| readers and subscribers to seek advice from a registered professiona| securities representative before deciding to trade in stocks featured within this report. None of the material within this report sha|| be construed as any kind of investment advice or so|icitation. Many of these companies are on the verge of bankruptcy. You can lose a|l your money by investing in this stock. The pub|isher of this report is not a registered investment expert. Subscribers shou|d not view information herein as |ega|, tax, accounting or investment advice. Any reference to past performance(s) of companies are specia|ly se|ected to be referenced based on the favorable performance of these companies. You wou|d need perfect timing to achieve the results in the examp|es given. There can be no assurance of that happening. Remember, as a|ways, past performance is not indicative of future results and a thorough due diligence effort, including a review of a company's filings at sec gov or edgar-online com when availab|e, shou|d be completed prior to investing. Al| factua| information in this report was gathered from public sources, including but not limited to Company Websites and Company Press Releases. The publisher of this report believes this information to be reliable but can make no assurance as to its accuracy or comp|eteness. Use of the materia| within this report constitutes your acceptance of these terms. If you wish to stop future mai|ings, or if you fee| you have been wrongful|y placed in our membership, please go here or send a blank e mai| with No Thanks in the subject to (-stox0029@yahoo.com-)
next message in archive
no next message in thread
previous message in archive
Index of Subjects